Structures by: Dobrzycki L.
Total: 71
C238.88H234F48N19.29Na4O87.2S2
C238.88H234F48N19.29Na4O87.2S2
Chemical Science (2019)
a=38.656(4)Å b=18.5689(19)Å c=22.026(2)Å
α=90° β=115.432(3)° γ=90°
C28H30F6N2O9
C28H30F6N2O9
Chemical Science (2019)
a=21.627(4)Å b=15.667(3)Å c=8.4646(18)Å
α=90° β=100.217(6)° γ=90°
C58.59H61.07F12K2N6.71O22.3
C58.59H61.07F12K2N6.71O22.3
Chemical Science (2019)
a=11.6762(5)Å b=14.1244(7)Å c=20.8720(10)Å
α=100.7753(16)° β=91.7229(17)° γ=99.9343(17)°
4-Chloropiperidine_monohydrate
C5H12ClNO
CrystEngComm (2021)
a=5.2628(2)Å b=25.4439(14)Å c=5.2264(3)Å
α=90° β=96.777(2)° γ=90°
4-Chloropiperidine_monohydrate
C5H12ClNO
CrystEngComm (2021)
a=5.2978(2)Å b=25.4806(15)Å c=5.2759(3)Å
α=90° β=97.132(2)° γ=90°
4-Methylpiperidine_hemihydrate
C12H28N2O
CrystEngComm (2021)
a=5.3056(4)Å b=23.544(2)Å c=11.1942(10)Å
α=90° β=99.188(2)° γ=90°
4-Chloropiperidine_trihydrate
C5H16ClNO3
CrystEngComm (2021)
a=12.4835(14)Å b=6.2084(5)Å c=12.2415(13)Å
α=90° β=95.025(4)° γ=90°
4-Chloropiperidine_trihydrate
C5H16ClNO3
CrystEngComm (2021)
a=12.5492(19)Å b=6.2375(7)Å c=12.3157(18)Å
α=90° β=94.551(5)° γ=90°
4-Methylpiperidine_trihydrate
C6H19NO3
CrystEngComm (2021)
a=13.176(3)Å b=6.3382(11)Å c=11.846(2)Å
α=90° β=103.596(7)° γ=90°
4-Methylpiperidine_trihydrate
C6H19NO3
CrystEngComm (2021)
a=13.2473(10)Å b=6.3988(4)Å c=11.8886(9)Å
α=90° β=103.251(2)° γ=90°
Catena-(bis(/m2-beta-Alanine)-lithium perchlotate)
C6H14LiN2O4,ClO4
CrystEngComm (2020)
a=8.3651(6)Å b=9.9433(7)Å c=27.584(2)Å
α=90° β=90° γ=90°
Catena-(/m-3-beta-Alanine-lithium perchlorate)
C3H7ClLiNO6
CrystEngComm (2020)
a=24.143(3)Å b=5.0111(7)Å c=14.528(2)Å
α=90° β=125.825(3)° γ=90°
Catena-(bis(/m-2-beta-Alanine)-lithium perchlorate)
C6H14LiN2O4,ClO4
CrystEngComm (2020)
a=4.9667(6)Å b=8.4410(11)Å c=13.9410(18)Å
α=90° β=95.899(4)° γ=90°
6-acetyl-4,7-dimethyl-5-[3-(morpholin-4-yl)propoxycoumarin
C20H25O5N
Med. Chem. Commun. (2017)
a=17.1277(16)Å b=9.9821(9)Å c=10.6929(9)Å
α=90° β=96.349(2)° γ=90°
4,7-dimethyl-5-{3-[4-(2-fluorophenyl)piperazin-1-yl]propoxy}coumarin
C24H27O3N2F
Med. Chem. Commun. (2017)
a=7.7995(6)Å b=9.8117(8)Å c=14.8527(12)Å
α=78.6250(19)° β=82.4050(18)° γ=69.9762(18)°
C74H85N2P2Zn2
C74H85N2P2Zn2
Chemical communications (Cambridge, England) (2010) 46, 41 7757-7759
a=12.6320(4)Å b=13.5140(5)Å c=21.8795(7)Å
α=73.9330(10)° β=89.0060(10)° γ=64.2620(10)°
C95H86N4P4Zn2
C95H86N4P4Zn2
Chemical communications (Cambridge, England) (2010) 46, 41 7757-7759
a=30.7145(15)Å b=9.7542(5)Å c=29.716(2)Å
α=90.00° β=119.1590(10)° γ=90.00°
C92H157N5O13
C92H157N5O13
Physical Chemistry Chemical Physics (2002) 4, 11 2387
a=9.773(2)Å b=17.050(3)Å c=27.745(6)Å
α=78.31(3)° β=89.92(3)° γ=77.10(3)°
C12H12Cl4N2
C12H12Cl4N2
CrystEngComm (2007) 9, 11 1029
a=7.5615(6)Å b=9.5420(8)Å c=19.8392(16)Å
α=90.00° β=90.00° γ=90.00°
C14H18Cl2N2
C14H18Cl2N2
CrystEngComm (2007) 9, 11 1029
a=7.5938(2)Å b=9.5918(3)Å c=20.0837(7)Å
α=90.00° β=90.00° γ=90.00°
C14H18Cl2N2
C14H18Cl2N2
CrystEngComm (2007) 9, 11 1029
a=8.1288(6)Å b=8.0393(5)Å c=45.532(3)Å
α=90.00° β=90.00° γ=90.00°
C14H18Cl2N2O2
C14H18Cl2N2O2
CrystEngComm (2007) 9, 11 1029
a=5.3605(3)Å b=8.1395(4)Å c=8.8621(5)Å
α=84.190(4)° β=73.687(5)° γ=88.389(5)°
C16H22Cl2N2O2
C16H22Cl2N2O2
CrystEngComm (2007) 9, 11 1029
a=16.221(2)Å b=16.221(2)Å c=6.7461(12)Å
α=90.00° β=90.00° γ=90.00°
C12H16Cl6N2O3
C12H16Cl6N2O3
CrystEngComm (2007) 9, 11 1029
a=14.938(2)Å b=5.2272(8)Å c=13.1403(16)Å
α=90.00° β=109.792(13)° γ=90.00°
C24H42Cl8N8O4
C24H42Cl8N8O4
CrystEngComm (2007) 9, 11 1029
a=21.7160(18)Å b=21.6971(16)Å c=7.6449(6)Å
α=90.00° β=93.524(6)° γ=90.00°
C14H24Cl2N2O2
C14H24Cl2N2O2
CrystEngComm (2007) 9, 2 152
a=10.0850(10)Å b=9.8110(10)Å c=17.9150(10)Å
α=90.00° β=101.6390(10)° γ=90.00°
C14H24Cl2N2O2
C14H24Cl2N2O2
CrystEngComm (2007) 9, 2 152
a=9.6460(10)Å b=9.9010(10)Å c=10.1480(10)Å
α=70.5390(10)° β=74.1320(10)° γ=80.8870(10)°
C28H38Cl3N4O6
C28H38Cl3N4O6
CrystEngComm (2007) 9, 2 152
a=13.1816(3)Å b=11.8826(3)Å c=22.3500(5)Å
α=90.00° β=90.00° γ=90.00°
C28H51Cl3N4O6
C28H51Cl3N4O6
CrystEngComm (2007) 9, 2 152
a=23.2912(9)Å b=11.9028(4)Å c=13.1852(5)Å
α=90.00° β=105.417(3)° γ=90.00°
C6H10Cl6N2Pb2
C6H10Cl6N2Pb2
CrystEngComm (2008) 10, 5 577
a=13.7009(18)Å b=7.8374(10)Å c=7.4351(7)Å
α=90.00° β=105.238(10)° γ=90.00°
C6H10Cl14Hg6N2O2
C6H10Cl14Hg6N2O2
CrystEngComm (2008) 10, 5 577
a=9.6706(12)Å b=10.9982(11)Å c=14.7910(16)Å
α=95.696(9)° β=101.053(10)° γ=99.407(9)°
C8H14Cl4N2Pb
C8H14Cl4N2Pb
CrystEngComm (2008) 10, 5 577
a=5.8696(5)Å b=11.4163(11)Å c=21.257(2)Å
α=90.00° β=95.871(7)° γ=90.00°
C8H14Cl10Hg4N2O
C8H14Cl10Hg4N2O
CrystEngComm (2008) 10, 5 577
a=11.0672(11)Å b=19.9418(15)Å c=11.9459(17)Å
α=90.00° β=107.754(11)° γ=90.00°
C20H38Cl6N4OPb
C20H38Cl6N4OPb
CrystEngComm (2008) 10, 5 577
a=12.2479(3)Å b=11.3720(3)Å c=20.7255(4)Å
α=90.00° β=90.632(2)° γ=90.00°
C11H20Cl4CuN2
C11H20Cl4CuN2
CrystEngComm (2008) 10, 5 577
a=17.7932(6)Å b=11.6083(4)Å c=7.8582(2)Å
α=90.00° β=90.00° γ=90.00°
C6H10Cl4N2Pb
C6H10Cl4N2Pb
CrystEngComm (2008) 10, 5 577
a=20.384(2)Å b=8.4343(9)Å c=6.9922(8)Å
α=90.00° β=93.669(9)° γ=90.00°
C255H88Cl17N33Pb3
C255H88Cl17N33Pb3
CrystEngComm (2008) 10, 5 577
a=13.7786(6)Å b=34.1194(14)Å c=18.7021(7)Å
α=90.00° β=90.00° γ=90.00°
C6H12Cl6Hg2N2O
C6H12Cl6Hg2N2O
CrystEngComm (2008) 10, 5 577
a=6.2678(8)Å b=10.9577(15)Å c=12.7211(18)Å
α=72.358(12)° β=79.396(11)° γ=75.428(12)°
C6H6BiCl4N3
C6H6BiCl4N3
CrystEngComm (2008) 10, 5 577
a=7.4183(5)Å b=8.2559(6)Å c=10.1905(7)Å
α=82.378(6)° β=79.922(5)° γ=84.856(6)°
C12H10CdCl8N2O3
C12H10CdCl8N2O3
CrystEngComm (2008) 10, 5 525
a=29.3171(15)Å b=6.7258(2)Å c=10.7881(4)Å
α=90.00° β=90.00° γ=90.00°
C28H36CdCl6N4
C28H36CdCl6N4
CrystEngComm (2008) 10, 5 525
a=48.1953(10)Å b=8.2248(2)Å c=7.9892(2)Å
α=90.00° β=90.00° γ=90.00°
C24H24Cl10CuN4O2
C24H24Cl10CuN4O2
CrystEngComm (2008) 10, 5 525
a=25.3329(9)Å b=6.7202(2)Å c=18.5449(5)Å
α=90.00° β=90.00° γ=90.00°
C12H10Cl8CuN2O2
C12H10Cl8CuN2O2
CrystEngComm (2008) 10, 5 525
a=10.8203(9)Å b=13.0489(10)Å c=29.142(2)Å
α=90.00° β=91.024(6)° γ=90.00°
C14H18Cl4HgN2
C14H18Cl4HgN2
CrystEngComm (2008) 10, 5 525
a=23.7172(16)Å b=6.6016(6)Å c=23.7876(16)Å
α=90.00° β=107.361(6)° γ=90.00°
C14H18Cl4N2Pb
C14H18Cl4N2Pb
CrystEngComm (2008) 10, 5 525
a=28.384(6)Å b=8.0158(16)Å c=7.7897(16)Å
α=90.00° β=91.80(3)° γ=90.00°
C6H6Cl4NPb
C6H6Cl4NPb
CrystEngComm (2008) 10, 5 525
a=34.087(7)Å b=7.9663(12)Å c=7.6109(12)Å
α=90.00° β=97.438(15)° γ=90.00°
C10H17.4Cl6Cu2N2.2
C10H17.4Cl6Cu2N2.2
CrystEngComm (2008) 10, 5 577
a=6.2815(2)Å b=10.2466(6)Å c=13.9250(8)Å
α=90.00° β=95.672(4)° γ=90.00°
C12H10Cl2F8N2O2
C12H10Cl2F8N2O2
CrystEngComm (2007) 9, 11 1029
a=29.020(3)Å b=7.2098(7)Å c=7.3450(7)Å
α=90.00° β=94.869(8)° γ=90.00°
C13H9ClF8N2O
C13H9ClF8N2O
CrystEngComm (2007) 9, 11 1029
a=12.8813(6)Å b=7.2351(2)Å c=15.5983(8)Å
α=90.00° β=101.215(4)° γ=90.00°
C12H4F8N2
C12H4F8N2
CrystEngComm (2007) 9, 11 1029
a=10.7907(4)Å b=8.9839(4)Å c=23.1750(8)Å
α=90.00° β=90.00° γ=90.00°
C14H18Cl2N2
C14H18Cl2N2
CrystEngComm (2007) 9, 11 1029
a=23.811(6)Å b=6.1672(14)Å c=4.9037(13)Å
α=90.00° β=100.84(2)° γ=90.00°
4-Methylpiperidine_hemihydrate
C12H28N2O
CrystEngComm (2021)
a=5.3447(4)Å b=23.720(2)Å c=11.2047(9)Å
α=90° β=99.241(2)° γ=90°
C20H27Ag5N10O18S4
C20H27Ag5N10O18S4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 2 396-402
a=7.1273(7)Å b=14.2131(9)Å c=34.705(2)Å
α=90.00° β=90.00° γ=90.00°
C2H2O4,C2HO4,2(H2O),H4N
C2H2O4,C2HO4,2(H2O),H4N
Acta crystallographica Section B, Structural science, crystal engineering and materials (2014) 70, Pt 5 847-855
a=6.2372(4)Å b=7.1935(5)Å c=10.4745(7)Å
α=94.5207(18)° β=99.8882(18)° γ=96.7177(19)°
Ga0.96Mn0.04N
Ga0.96Mn0.04N
Chemistry of Materials (2007) 19, 13 3139
a=3.1932(15)Å b=3.1932(15)Å c=5.185(3)Å
α=90.00° β=90.00° γ=120.00°
Pyrrolidine hexahydrate - LT phase at 190K
C4H21NO6
Crystal Growth & Design (2015) 15, 10 4804
a=7.8605(9)Å b=8.1447(8)Å c=8.6837(10)Å
α=90.00° β=103.559(4)° γ=90.00°
Pyrrolidine hexahydrate - HT phase at 269K
C4H21NO6
Crystal Growth & Design (2015) 15, 10 4804
a=13.044(2)Å b=10.3955(16)Å c=8.2250(11)Å
α=90.00° β=90.00° γ=90.00°
THF clathrate hydrate type sII
C4H42O18
Crystal Growth & Design (2015) 15, 10 4804
a=17.2166(11)Å b=17.2166(11)Å c=17.2166(11)Å
α=90.00° β=90.00° γ=90.00°
Pyrrolidine LT phase at 135K
C4H9N
Crystal Growth & Design (2015) 15, 10 4804
a=8.6611(17)Å b=5.2080(9)Å c=10.672(2)Å
α=90.00° β=110.561(6)° γ=90.00°
Pyrrolidine LT phase at 205K
C4H9N
Crystal Growth & Design (2015) 15, 10 4804
a=8.740(2)Å b=5.2169(13)Å c=10.816(3)Å
α=90.00° β=110.284(8)° γ=90.00°
Pyrrolidine - HT phase at 165K
C4H9N
Crystal Growth & Design (2015) 15, 10 4804
a=5.3132(6)Å b=10.6916(15)Å c=16.268(2)Å
α=90.00° β=90.00° γ=90.00°
Pyrrolidine hexahydrate - LT phase at 100K
C4H21NO6
Crystal Growth & Design (2015) 15, 10 4804
a=7.7347(7)Å b=8.0940(8)Å c=8.6976(8)Å
α=90.00° β=103.683(3)° γ=90.00°
Pyrrolidine hemihydrate at 190K
C8H20N2O
Crystal Growth & Design (2015) 15, 10 4804
a=19.2938(10)Å b=12.3590(6)Å c=8.6638(4)Å
α=90.00° β=98.0980(10)° γ=90.00°
Pyrrolidine hexahydrate - LT phase at 150K
C4H21NO6
Crystal Growth & Design (2015) 15, 10 4804
a=7.7773(12)Å b=8.1088(12)Å c=8.6962(13)Å
α=90.00° β=103.605(4)° γ=90.00°
C8H9N3O3
C8H9N3O3
Crystal Growth & Design (2011) 11, 6 2074
a=7.943(2)Å b=23.633(6)Å c=4.8675(12)Å
α=90.00° β=104.864(6)° γ=90.00°
C8H9N3O3
C8H9N3O3
Crystal Growth & Design (2011) 11, 6 2074
a=7.962(3)Å b=24.157(9)Å c=4.8805(18)Å
α=90.00° β=104.597(9)° γ=90.00°
C8H9N3O3
C8H9N3O3
Crystal Growth & Design (2011) 11, 6 2074
a=12.7022(11)Å b=3.8175(2)Å c=17.3647(16)Å
α=90.00° β=91.632(7)° γ=90.00°
Pyrrolidine hexahydrate - HT phase at 210K
C4H21NO6
Crystal Growth & Design (2015) 15, 10 4804
a=12.9839(19)Å b=10.3156(15)Å c=8.2093(10)Å
α=90.00° β=90.00° γ=90.00°
Pyrrolidine - HT phase at 207K
C4H9N
Crystal Growth & Design (2015) 15, 10 4804
a=5.3112(5)Å b=10.7769(13)Å c=16.432(2)Å
α=90.00° β=90.00° γ=90.00°
C8H11N3O4
C8H11N3O4
Crystal Growth & Design (2011) 11, 6 2074
a=22.6561(14)Å b=11.7274(7)Å c=7.3264(4)Å
α=90.00° β=102.933(5)° γ=90.00°
Slavikite
Fe5H66Mg2O67.669S7
American Mineralogist (2010) 95, 11-18
a=12.1347Å b=12.1347Å c=34.706Å
α=90° β=90° γ=120°